- Home
- VTAK vs XPON Comparison
VTAK vs XPON Comparison
Compare VTAK & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- XPON
- Stock Information
- Founded
- VTAK 2002
- XPON 2016
- Country
- VTAK United States
- XPON United States
- Employees
- VTAK N/A
- XPON N/A
- Industry
- VTAK Medical/Dental Instruments
- XPON Electronic Components
- Sector
- VTAK Health Care
- XPON Technology
- Exchange
- VTAK Nasdaq
- XPON Nasdaq
- Market Cap
- VTAK 3.1M
- XPON 3.0M
- IPO Year
- VTAK 2018
- XPON 2022
- Fundamental
- Price
- VTAK $0.17
- XPON $1.12
- Analyst Decision
- VTAK
- XPON
- Analyst Count
- VTAK 0
- XPON 0
- Target Price
- VTAK N/A
- XPON N/A
- AVG Volume (30 Days)
- VTAK 1.9M
- XPON 3.0M
- Earning Date
- VTAK 08-13-2025
- XPON 08-13-2025
- Dividend Yield
- VTAK N/A
- XPON N/A
- EPS Growth
- VTAK N/A
- XPON N/A
- EPS
- VTAK N/A
- XPON N/A
- Revenue
- VTAK $481,000.00
- XPON $6,702,411.00
- Revenue This Year
- VTAK $822.86
- XPON $61.26
- Revenue Next Year
- VTAK $168.42
- XPON N/A
- P/E Ratio
- VTAK N/A
- XPON N/A
- Revenue Growth
- VTAK 9.57
- XPON 23.07
- 52 Week Low
- VTAK $0.15
- XPON $0.60
- 52 Week High
- VTAK $2.49
- XPON $50.12
- Technical
- Relative Strength Index (RSI)
- VTAK 31.31
- XPON 51.70
- Support Level
- VTAK $0.20
- XPON $1.11
- Resistance Level
- VTAK $0.24
- XPON $1.50
- Average True Range (ATR)
- VTAK 0.02
- XPON 0.18
- MACD
- VTAK -0.01
- XPON -0.01
- Stochastic Oscillator
- VTAK 4.13
- XPON 33.89
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.